ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

VELTASSA
Electrolyte disturbances
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

VELTASSA Rx

Generic Name and Formulations:
Patiromer 8.4g, 16.8g, 25.2g; per pkt; pwd for oral susp.

Company:
Relypsa, Inc.

Therapeutic Use:

Indications for VELTASSA:

Hyperkalemia.

Limitations Of use:

Not for emergency treatment for life-threatening hyperkalemia due to its delayed onset of action.

Adult:

Give at least 3hrs before or 3hrs after other oral medications. Take with food. Initially 8.4g once daily. Adjust dose in 8.4g increments as needed at ≥1-week intervals to obtain desired serum potassium target range; max 25.2g/day.

Children:

Not established.

Warnings/Precautions:

Monitor serum potassium, magnesium. Consider magnesium supplementation if low serum levels develop. Severe constipation, bowel obstruction or impaction, abnormal post-op bowel motility disorders; avoid.

Interactions:

May reduce absorption and efficacy of other oral medications; separate dosing by at least 3hrs.

Pharmacological Class:

Potassium binder.

Adverse Reactions:

Constipation, hypomagnesemia, diarrhea, nausea, abdominal discomfort, flatulence.

Generic Availability:

NO

How Supplied:

Single-use packets (8.4g)—4, 30; (16.8g, 25.2g)—30

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs